Back to search
Hypertension Pulmonary Secondary Heart Failure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypertension Pulmonary Secondary Heart Failure trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypertension Pulmonary Secondary Heart Failure trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
PH-HFpEF patients will receive open-label doses of levosimendan and be periodically evaluated for safety in extended use.
This study aims to determine the efficacy of sildenafil (improve PAH) as an add-on therapy to dapagliflozin in the treatment of heart failure patients with seco…